Taiho Pharmaceutical Co., Ltd. drugs

2 results

  • inqovi

    (CEDAZURIDINE and DECITABINE)
    Taiho Pharmaceutical Co., Ltd.
    INQOVI is indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including various subtypes and risk groups as per the International Prognostic Scoring System, applicable to both previously treated and untreated cases.
    Medication Details
    Drug Interactions

  • lonsurf

    (trifluridine and tipiracil)
    Taiho Pharmaceutical Co., Ltd.
    LONSURF is indicated for adult patients with metastatic colorectal cancer previously treated with specified chemotherapy regimens and targeted therapies, and for those with metastatic gastric or gastroesophageal junction adenocarcinoma after two prior chemotherapy lines involving fluoropyrimidine and platinum-based treatments.
    Medication Details
    Drug Interactions